Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX1 | Q96LB2 | 3/20 | 0.68 |
| ▸ | F2 | P00734 | 2/20 | 0.68 |
| ▸ | F10 | P00742 | 2/20 | 0.68 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.68 |
| ▸ | F7 | P08709 | 2/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | BCHE | P06276 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NPY2R | P49146 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL28570903 | 0.99 | MRGPRX1 (0.67) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL1186351 | 0.86 | ALDH1A1 (0.68) | SMN1; SMN2KDM4EKMT2AALDH1A1 | |
| SCHEMBL17894411 | 0.85 | ALDH1A1 (0.59) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL6673419 | 0.83 | BCHE (0.61) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL17894434 | 0.83 | SMARCA2 (0.55) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL9416614 | 0.82 | LMNA (0.73) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL9416664 | 0.81 | NPC1 (0.69) | NPC1PKMRAB9ABCHELMNA | |
| SCHEMBL5525095 | 0.81 | BCHE (0.64) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL3051565 | 0.81 | LMNA (0.74) | MRGPRX1F2F10PRSS1F7 | |
| SCHEMBL9416636 | 0.81 | SMPD1 (0.70) | MRGPRX1F2F10PRSS1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220031666-A1 | PPARo ACTIVATOR | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2022-02-03 | — | — | US | disclosed |
| WO-2020085393-A1 | PPARδ ACTIVATOR | 国立研究開発法人科学技術振興機構 | 2020-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220031666-A1 | PPARo ACTIVATOR | PPARG, PPARD, PPARA | MRGPRX1 2982/4885F2 4571/4885F10 4765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.